Natural science

NSERC Awards Funding to TRIUMF and General Fusion to Develop State-of-the-Art Diagnostic System for LM26 Fusion Machine

Retrieved on: 
Wednesday, March 27, 2024
Natural science, Plasma, University, Health, Science, Research, General Fusion, Neutron, Engineering, TRIUMF, Simon Fraser University, Lithium

The neutron spectrometer system is a flagship project under the collaborative agreement signed by TRIUMF and General Fusion in 2023 .

Key Points: 
  • The neutron spectrometer system is a flagship project under the collaborative agreement signed by TRIUMF and General Fusion in 2023 .
  • Known for pushing the boundaries of science and innovation, TRIUMF will support General Fusion in developing a diagnostic system capable of precisely measuring neutron energies at a very high rate.
  • Neutrons carry unique information about fusion reactions, and the system being built at TRIUMF and General Fusion will tag neutron interactions every nanosecond.
  • “This exciting project highlights the deep technology collaboration happening across the country to advance Canadian fusion energy technology,” said Greg Twinney, CEO, General Fusion.

Lingyun Xiang elected as a foreign academician of the European Academy of Natural Sciences

Retrieved on: 
Tuesday, March 26, 2024
Natural science

Hanover,Germany, March 26, 2024 (GLOBE NEWSWIRE) -- According to the European Academy of Natural Sciences , after several rounds of rigorous academic review and selection procedures, Professor Xiang Lingyun, an economist based in the United States, was elected as a foreign academician of the European Academy of Natural Sciences.

Key Points: 
  • Hanover,Germany, March 26, 2024 (GLOBE NEWSWIRE) -- According to the European Academy of Natural Sciences , after several rounds of rigorous academic review and selection procedures, Professor Xiang Lingyun, an economist based in the United States, was elected as a foreign academician of the European Academy of Natural Sciences.

Securing Canada's AI advantage

Retrieved on: 
Sunday, April 7, 2024
First Nations, Child care, Natural language processing, NRC, Artificial intelligence, Child, Deep learning, Parliament, Investment, Democracy, Cohere, SSHRC, Woman, Safety, G7, Natural science, Drug discovery, Canada national team, Commons, Agriculture, Federation, Act, Research, Regional development agency, IRAP, Food, IBM, House, AIDA, National Research Council, Coveo, Digital, Health, Millennials, OpenText, Government, Growth, Today, TELUS, Public, Advisory Council, Working Group, Life, Housing, Ecosystem, BlackBerry, Social science, CIHR, Medical device

The Prime Minister, Justin Trudeau, today announced a $2.4 billion package of measures from the upcoming Budget 2024 to secure Canada's AI advantage.

Key Points: 
  • The Prime Minister, Justin Trudeau, today announced a $2.4 billion package of measures from the upcoming Budget 2024 to secure Canada's AI advantage.
  • We will also develop a new Canadian AI Sovereign Compute Strategy to catalyze the development of Canadian-owned and located AI infrastructure.
  • Creating a new Canadian AI Safety Institute, with $50 million to further the safe development and deployment of AI.
  • Today's announcement is about investing in innovation and economic growth to secure Canada's world-leading AI advantage today and for generations to come.

Egle Therapeutics Strengthens its Leadership Team with the Appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer

Retrieved on: 
Wednesday, March 27, 2024
Science, Stem Cells, Biotechnology, Research, Pharmaceutical, Oncology, Health, Clinical Trials, Egle, Natural science, Leukemia, Patient, Cell biology, CMC, Head, Doctor of Philosophy, MD, IND, Clinical trial, Investigational New Drug, Therapy, International school, CSO, Pharmaceutical industry

Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer.

Key Points: 
  • Egle Therapeutics, a biotechnology company focused on advancing the next generation of regulatory T cell-focused therapies for oncology and auto-immunity, announced today the appointment of Monica Gostissa, PhD, as Chief Scientific Officer and Reno Winter, PhD, as Chief Technical Officer.
  • “I'm excited to join Egle Therapeutics to help develop novel immunotherapies targeting T regulatory cells for oncology and autoimmune diseases.
  • “I am happy to be part of Egle Therapeutics’ leadership team to contribute my expertise in CMC and beyond to the company’s mission.
  • Dr. Winter is a trained biochemist and received his PhD in Natural Sciences from the Martin Luther University Halle-Wittenberg, Germany.

Calico Appoints Michael Lenardo, M.D., as Chief Scientific Officer

Retrieved on: 
Thursday, March 28, 2024
Internal medicine, University, Natural science, Biomedicine, Alphabet, Calico (company), Immune system, SAN, Research, Science, Whitehead Institute, National academy, Biology, Biochemistry, Johns Hopkins University, NIAID, Most, Nobel, Bangladesh Technical Education Board, Birth, Biomedical Research, O.B.E, Infection, Ageing, Pharmaceutical industry

SOUTH SAN FRANCISCO, Calif., March 28, 2024 /PRNewswire/ -- Calico Life Sciences LLC (Calico), a biotechnology organization focused on the biology of aging and age-related diseases, and founded by Alphabet and Arthur D. Levinson, Ph.D., today announced the appointment of Michael Lenardo, M.D., as its new Chief Scientific Officer.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., March 28, 2024 /PRNewswire/ -- Calico Life Sciences LLC (Calico), a biotechnology organization focused on the biology of aging and age-related diseases, and founded by Alphabet and Arthur D. Levinson, Ph.D., today announced the appointment of Michael Lenardo, M.D., as its new Chief Scientific Officer.
  • Dr. Lenardo is an accomplished molecular immunologist and geneticist whose medical research career spans four decades.
  • "Securing someone of Mike's caliber for the critical role of Chief Scientific Officer is a major achievement for Calico," said Dr. Levinson, CEO of Calico.
  • "The commitment to scientific excellence and integrity at Calico, coupled with the highly talented team, is truly impressive and reflected in the impactful progress they are making.

Innovative Medicines Canada welcomes Bettina Hamelin as new President

Retrieved on: 
Tuesday, March 19, 2024
Health, Natural science, Organization, Biotechnology, Doctor of Pharmacy, Commercialization, Science, Drug discovery, COVID-19, Knowledge, Research, Technology transfer, Engineering, Ontario Genomics, EMBA, Creative, Interim, Vaccine, Innovative Medicines Canada, Pharmaceutical industry

OTTAWA, ON, March 19, 2024 /CNW/ - Innovative Medicines Canada (IMC) is pleased to announce Dr. Bettina Hamelin has been appointed as its new President, effective April 8, 2024.

Key Points: 
  • OTTAWA, ON, March 19, 2024 /CNW/ - Innovative Medicines Canada (IMC) is pleased to announce Dr. Bettina Hamelin has been appointed as its new President, effective April 8, 2024.
  • Dr. Hamelin, PharmD, EMBA, comes to IMC with over 30 years of experience in academia, industry, and not-for-profit organizations.
  • "It's an honour to advocate for an industry that continually leverages the power of science to improve the health and well-being of Canadians," said Bettina Hamelin, Incoming President of Innovative Medicines Canada.
  • Dr. Hamelin will assume the role from David Renwick, who has been Interim President of Innovative Medicines Canada since November 2023.

University of Maryland Receives $27.2 Million Gift to Support Mathematics Research and Outreach

Retrieved on: 
Thursday, March 14, 2024
College, Natural science, Performance studies, Computer science, Knowledge, Research, University, Faculty, Student, Statistics, News, NASA, UMD, Computer, Parent, School, Tutoring

COLLEGE PARK, Md., March 14, 2024 /PRNewswire/ -- The University of Maryland announced today a $27.2 million gift to the Department of Mathematics to endow the Brin Mathematics Research Center, establish a new Brin Endowed Chair in Mathematics and pilot the Brin Maryland Mathematics Camp for talented high school students in the state.

Key Points: 
  • The gift is the latest from UMD mathematics Professor Emeritus Michael Brin and his wife Eugenia, a retired NASA scientist, who established the Brin Mathematics Research Center in December 2021 with a $4.75 million gift.
  • "We are always happy to help support the Department of Mathematics at the University of Maryland," said Michael Brin.
  • "The research at the Brin Mathematics Research Center expands our mathematics and statistics understanding and showcases excellence here at the University of Maryland."
  • "The Brin Mathematics Research Center makes the University of Maryland a destination for mathematics and statistics research," said Doron Levy, the center's director and chair of the Department of Mathematics.

Government of Canada invests in 7,700 world-class researchers and projects across the country

Retrieved on: 
Wednesday, March 13, 2024
Natural science, Government, Climate change, Transport, CFI, University, TIPS, Public, Humanities, SSHRC, Knowledge, Society, The Honourable, Research, Acquisition, RSF, Engineering, Quality of life, Student, Investment, CRC, Social, Scholarship, IPG, Social science, CIHR

It will support the acquisition of the state-of-the-art tools and infrastructure needed by researchers to advance their discoveries and innovations.

Key Points: 
  • It will support the acquisition of the state-of-the-art tools and infrastructure needed by researchers to advance their discoveries and innovations.
  • The funding is distributed across the country through:
    The Canada Research Chairs (CRC) program – awarding $191 million to 230 new and renewed chairholders at 50 institutions.
  • "Congratulations to top-tier researchers who will get a boost through this vital funding to take their projects to the next level.
  • CFI's John R. Evans Leaders Fund helps institutions attract and retain researchers and provides support for the Canada Research Chairs Program.

IMS Developing Japan's First "Cold (Neutral) Atom" Quantum Computers: New Collaboration with 10 Industry Partners toward Commercialization

Retrieved on: 
Tuesday, March 12, 2024
Temperature, Natural science, Innovation, Growth, Commercialization, Development finance institution, Professor, Business, Internet, Research, Electronics, Artificial intelligence, University, Software, Computer, Quantum, IMS, Architecture, NEC, University of California, Hitachi, Optical tweezers, Fujitsu, Bangladesh Technical Education Board, Silicon, Microscope

The launch of the PF was made possible by collaboration with 10 industry partners, including companies and financial institutions.

Key Points: 
  • The launch of the PF was made possible by collaboration with 10 industry partners, including companies and financial institutions.
  • It plans to launch a start-up company by the end of its FY2024 and begin the development of "cold (neutral) atom" quantum computers.
  • The Ohmori group at the IMS is leading the world in developing the cold (neutral) atom quantum computers.
  • By taking advantage of these technical advances and core competencies of the Ohmori group, the IMS will accelerate the development and commercialization of quantum computers in collaboration with its industry partners.

IMS Developing Japan's First "Cold (Neutral) Atom" Quantum Computers: New Collaboration with 10 Industry Partners toward Commercialization

Retrieved on: 
Tuesday, March 12, 2024
Temperature, Natural science, Innovation, Growth, Commercialization, Development finance institution, Professor, Business, Internet, Research, Electronics, Artificial intelligence, University, Software, Computer, Quantum, IMS, Architecture, NEC, University of California, Hitachi, Optical tweezers, Fujitsu, Bangladesh Technical Education Board, Silicon, Microscope

The launch of the PF was made possible by collaboration with 10 industry partners, including companies and financial institutions.

Key Points: 
  • The launch of the PF was made possible by collaboration with 10 industry partners, including companies and financial institutions.
  • It plans to launch a start-up company by the end of its FY2024 and begin the development of "cold (neutral) atom" quantum computers.
  • The Ohmori group at the IMS is leading the world in developing the cold (neutral) atom quantum computers.
  • By taking advantage of these technical advances and core competencies of the Ohmori group, the IMS will accelerate the development and commercialization of quantum computers in collaboration with its industry partners.